Daniel C. Martin

Business address
C/O Deciphera Pharmaceuticals, Inc., 200 Smith Street, Waltham, MA, 02451
Top holdings (ownership)
DCPH
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Daniel C. Martin has filed 20 SEC EDGAR filings since 20 Sep 2018

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 4 11 Jun 2024 11 Jun 2024 001-38219
4 Open Document Open Filing 4 20 Feb 2024 15 Feb 2024 001-38219
4 Open Document Open Filing 4 18 Jan 2024 16 Jan 2024 001-38219
4 Open Document Open Filing 4 14 Dec 2023 12 Dec 2023 001-38219
4 Open Document Open Filing 4 01 Dec 2023 30 Nov 2023 001-38219
144 Open Document Open Filing 30 Nov 2023
4 Open Document Open Filing FORM 4 SUBMISSION 31 Oct 2023 28 Oct 2023 001-38219
4 Open Document Open Filing FORM 4 SUBMISSION 21 Jun 2023 16 Jun 2023 001-38219
4 Open Document Open Filing FORM 4 SUBMISSION 17 Feb 2023 15 Feb 2023 001-38219
4 Open Document Open Filing FORM 4 SUBMISSION 19 Jan 2023 17 Jan 2023 001-38219
4 Open Document Open Filing FORM 4 SUBMISSION 21 Jun 2022 16 Jun 2022 001-38219
4 Open Document Open Filing FORM 4 SUBMISSION 18 Feb 2022 16 Feb 2022 001-38219
4 Open Document Open Filing FORM 4 SUBMISSION 20 Jan 2022 18 Jan 2022 001-38219
4 Open Document Open Filing FORM 4 SUBMISSION 17 Dec 2021 15 Dec 2021 001-38219
3 Open Document Open Filing FORM 3 SUBMISSION 02 Apr 2021 23 Mar 2021 001-38219
4 Open Document Open Filing FORM 4 SUBMISSION 24 Jan 2020 22 Jan 2020 001-38219
4 Open Document Open Filing FORM 4 SUBMISSION 23 Sep 2019 19 Sep 2019 001-38219
4 Open Document Open Filing FORM 4 SUBMISSION 01 Feb 2019 30 Jan 2019 001-38219
4 Open Document Open Filing FORM 4 SUBMISSION 20 Sep 2018 18 Sep 2018 001-38219
3 Open Document Open Filing FORM 3 SUBMISSION 20 Sep 2018 18 Sep 2018 001-38219